News

Press Releases
Kane Biotech Announces Rights Offering

WINNIPEG, Manitoba – March 29, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced that it will be offering rights (“Rights”) to holders (“Shareholders”) of its common shares (“Common Shares”) of record as at 5:00 p.m.…

> Read More

Press Releases
Kane Biotech Expanding bluestem™ to the USA

WINNIPEG, Manitoba – March 1, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce it will be launching its bluestem™ brand of premium pet oral care products at Global Pet Expo in Orlando Florida…

> Read More

Press Releases
Kane Biotech Announces Private Placement Offering

WINNIPEG, Manitoba –(Marketwired – January 27, 2016) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced the intention of the Company to undertake a non-brokered private placement offering (the “Offering”) of up to 66,666,667 units (“Units”) at…

> Read More

Press Releases
Kane Biotech receives $240,000 from Warrant Exercise

WINNIPEG, Manitoba –(Marketwired – January 08, 2016) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that between December 30, 2015 and January 4, 2016 it received $240,000 from the exercising of 4,000,000 warrants at $.06 per share. The warrants were…

> Read More

Press Releases
Kane Biotech appoints new CFO and announces addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options

WINNIPEG, Manitoba –(Marketwired – January 05, 2016) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) a biotechnology company developing and commercializing products that prevent and remove microbial biofilms is pleased to appoint Audrey Goertzen CPA, CGA as Kane Biotech’s new Chief…

> Read More

Press Releases
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba –(Marketwired – December 31, 2015) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that on December 30, 2015, it issued 251,392 common shares of the Corporation (“Common Shares”) in payment of $12,569.62 in interest owing on the Corporation’s…

> Read More

Press Releases
Kane Biotech Announces Amendments to Terms of Convertible Note and Warrants

WINNIPEG, Manitoba –(Marketwired – December 14, 2015) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the Corporation has entered into an agreement to: (a) extend the maturity date of its previously issued $500,000 principal amount…

> Read More